Folic acid supplementation for the prevention of neural tube defects: promotion and use

References

• Guthkelch AN. Studies in spina bifida cystica. III. Seasonal variation in the frequency of spina bifida births. Br J Prev Soc Med. 1962;16: 159–162.
   PubMedGoogle Scholar
• Loeken MR. Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet CSemin Med Genet. 2005;135C(1):77–87.
   Web of Science ®Google Scholar
• Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005;105(2):261–265.
   PubMed Web of Science ®Google Scholar
• Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and metaanalysis. Epidemiology. 2005;16(2):216–219.
   Web of Science ®Google Scholar
• Defoort EN, Kim PM, Winn LM. Valproic acid increases conservative homologous recombination frequency and reactive oxygen species formation: a potential mechanism for valproic acid-induced neural tube defects. Mol Pharmacol. 2006;69(4):1304–1310.
   Web of Science ®Google Scholar
• Botto LD, Yang Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862–877.
   PubMed Web of Science ®Google Scholar
• van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346(8982):1070–1071.
   PubMed Web of Science ®Google Scholar
• Mitchell HK, Snell EE, Williams RJ. The concentration of “folic acid.” Nutr Rev. 1988;46(9):324–325.
   Google Scholar
• Nutritional anaemias. World Health Organ Tech Rep Ser. 405. Geneva, Switzerland: World Health Organization; 1968.
   Google Scholar
• Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med. 2004;350(2):134–142.
   PubMed Web of Science ®Google Scholar
• Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp. 1994;181:180–187.
   PubMedGoogle Scholar
• Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274(21): 1698–1702.
   PubMed Web of Science ®Google Scholar
• Hibbard BM, Hibbard ED. Aetiological factors in abruptio placentae. Br Med J. 1963;2(5370):1430–1436.
   Google Scholar
• Hall MH. Folic acid deficiency and congenital malformation. J Obstet GynaecolBr Commonw. 1972;79(2):159–161.
   Google Scholar
• Smithells RW, Sheppard S, Schorah CJ. Vitamin dificiencies and neural tube defects. Arch Dis Child. 1976;51(12):944–950.
   PubMed Web of Science ®Google Scholar
• Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1983;1(8332):1027–1031.
   Web of Science ®Google Scholar
• Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn. 1990;10(3):149–152.
   Web of Science ®Google Scholar
• Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconcep- tional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6(3):219–226.
   PubMed Web of Science ®Google Scholar
• MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131–137.
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl JMed. 1992; 327(26):1832–1835.
   PubMed Web of Science ®Google Scholar
• Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001;(3):CD001056.
   Web of Science ®Google Scholar
• Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992; 41(RR-14):1–7.
   Google Scholar
• Cornel MC, Erickson JD. Comparison of national policies on peri- conceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology. 1997;55(2):134–137.
   Google Scholar
• Chacko MR, Anding R, Kozinetz CA, Grover JL, Smith PB. Neural tube defects: knowledge and preconceptional prevention practices in minority young women. Pediatrics. 2003;112(3 Pt 1):536–542.
   Web of Science ®Google Scholar
• van der Pal-de Bruin KM, de Walle HE, de Rover CM, et al. Influence of educational level on determinants of folic acid use. Paediatr Perinat Epidemiol. 2003;17(3):256–263.
   Web of Science ®Google Scholar
• Raats MM, Thorpe L, Hurren C, Elliott K. The health education authority’s folic acid campaign. BNF Nutr Bull. 1998;23:156–162.
   Google Scholar
• Bower C, Blum L, O’Daly K, Higgins C, Loutsky F, Kosky C. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Aust N Z J Public Health. 1997;21(7):716–721.
   Web of Science ®Google Scholar
• Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341(20): 1485–1490.
   PubMed Web of Science ®Google Scholar
• Amitai Y, Fisher N, Haringman M, Meiraz H, Baram N, Leventhal A. Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign. Prev Med. 2004;39(4):731–737.
   Web of Science ®Google Scholar
• Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG. 2004;111(5): 399–08.
   Web of Science ®Google Scholar
• de Jong-van den Berg LT, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol. 2005; 192(1):121–128.
   PubMed Web of Science ®Google Scholar
• Han JY, Nava-Ocampo AA, Koren G. Unintended pregnancies and exposure to potential human teratogens. Birth Defects Res A Clin Mol Teratol. 2005;73(4):245–248.
   Google Scholar
• Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30(1):24–29, 46.
   PubMedGoogle Scholar
• Green-Raleigh K, Carter H, Mulinare J, Prue C, Petrini J. Trends in folic acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995–2005. Matern Child Health J. 2006;10 Suppl 5:S177–S182.
   Google Scholar
• Daltveit AK, Vollset SE, Lande B, Oien H. Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998–2000. Scand J Public Health. 2004;32(4):264–271.
   Web of Science ®Google Scholar
• French MR, Barr SI, Levy-Milne R. Folate intakes and awareness of folate to prevent neural tube defects: a survey of women living in Vancouver, Canada. J Am Diet Assoc. 2003;103(2):181–185.
   Google Scholar
• Abdulrazzaq YM, Al Gazali LI, Bener A, et al. Folic acid awareness and intake survey in the United Arab Emirates. Reprod Toxicol. 2003; 17(2):171–176.
   Web of Science ®Google Scholar
• Frishman GN, Spurrell TP, Heber WW. Folic acid. Preconception knowledge and use by infertile women. J Reprod Med. 2001;46(12): 1025–1030.
   Web of Science ®Google Scholar
• Massi Lindsey LL, Silk KJ, Friederichs-Fitzwater MM, Hamner HC, Prue CE, Boster FJ. Developing effective campaign messages to prevent neural tube defects: a qualitative assessment of women’s reactions to advertising concepts. J Health Commun. 2009;14(2):131–159.
   Web of Science ®Google Scholar
• Bower C, Miller M, Payne J, Serna P. Promotion of folate for the prevention of neural tube defects: who benefits? Paediatr Perinat Epidemiol. 2005;19(6):435–444.
   Web of Science ®Google Scholar
• Tam LE, McDonald SD, Wen SW, Smith GN, Windrim RC, Walker MC. A survey of preconceptional folic acid use in a group of Canadian women. J Obstet Gynaecol Can. 2005;27(3):232–236.
   Google Scholar
• Flores AL, Prue CE, Daniel KL. Broadcasting behavior change: a comparison of the effectiveness of paid and unpaid media to increase folic acid awareness, knowledge, and consumption among Hispanic women of childbearing age. Health Promot Pract. 2007;8(2):145–153.
   Google Scholar
• Forster DA, Wills G, Denning A, Bolger M. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery. 2009;25(2):134–146.
   PubMed Web of Science ®Google Scholar
• Williams JL, Abelman SM, Fassett EM, et al. Health care provider knowledge and practices regarding folic acid, United States, 2002–2003. Matern Child Health J. 2006;10 Suppl 5:S67–S72.
   Google Scholar
• Stockley L, Lund V. Use of folic acid supplements, particularly by low-income and young women: a series of systematic reviews to inform public health policy in the UK. Public Health Nutr. 2008;11(8): 807–821.
   PubMed Web of Science ®Google Scholar
• Chivu CM, Tulchinsky TH, Soares-Weiser K, Braunstein R, Brezis M. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am J Health Promot. 2008;22(4):237–245.
   Web of Science ®Google Scholar
• Botto LD, Lisi A, Robert-Gnansia E, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ. 2005; 330(7491):571.
   Google Scholar
• Food and Drug Administration. Amendment of standards of identity of enriched gram products to require addition of folic acid. Fed Regist. 1996;61:8781–8797.
   Google Scholar
• Health Canada. Regulations amending the food and drug regulations (1066). Canada Gazette, Part I. 1997;131:3702–3737.
   Google Scholar
• Food Safety Authority of Ireland. 2006. Annual report. Available from: http://www.fsai.ie/resources_and_publications/annual_reports.html.
   Google Scholar
• Centers for Disease Control and Prevention. Spina bifida and anen- cephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000. MMWR Morb Mortal Wkly Rep. 2004;53(17): 362–365.
   Google Scholar
• Lopez-Camelo JS, Orioli IM, da Graca DM, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A. 2005;135(2):120–125.
   Google Scholar
• De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007; 357(2):135–142.
   PubMed Web of Science ®Google Scholar
• Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr. 2009;102(2):173–180.
   PubMed Web of Science ®Google Scholar
• Pacheco SS, Braga C, Souza AI, Figueiroa JN. Effects of folic acid fortification on the prevalence of neural tube defects. Rev Saude Publica. 2009;43(4):565–571.
   Web of Science ®Google Scholar
• Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics. 2005;116(3):580–586.
   PubMed Web of Science ®Google Scholar
• Yang Q, Cogswell ME, Hamner HC, et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am J Clin Nutr. 2010;91(1):64–72.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr. 2007;86(3):718–727.
   PubMed Web of Science ®Google Scholar
• Quinlivan EP, Gregory JF, III. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2003;77(1): 221–225.
   PubMed Web of Science ®Google Scholar
• Ray JG, Vermeulen MJ, Boss SC, Cole DE. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology. 2002;13(2):238–240.
   Web of Science ®Google Scholar
• Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193–200.
   PubMed Web of Science ®Google Scholar
• Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006;367(9519):1352–1361.
   PubMed Web of Science ®Google Scholar
• Vollset SE, Gjessing HK, Tandberg A, et al. Folate supplementation and twin pregnancies. Epidemiology. 2005;16(2):201–205.
   Web of Science ®Google Scholar
• Mills JL, Von KI, Conley MR, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77(6):1474–1477.
   Web of Science ®Google Scholar
• Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med. 1998;129(7):517–524.
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control. 2002;13(3):239–248.
   PubMed Web of Science ®Google Scholar
• Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132 Suppl 8:S2350–S2355.
   Google Scholar
• Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10(2):66–88.
   PubMed Web of Science ®Google Scholar
• Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825–828.
   PubMed Web of Science ®Google Scholar
• Van Guelpen B, Hultdin J, Johansson I, et al. Low folate levels may protect against colorectal cancer. Gut. 2006;55(10):1461–1466.
   Web of Science ®Google Scholar
• Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351–2359.
   PubMed Web of Science ®Google Scholar
• Wu K, Platz EA, Willett WC, et al. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr. 2009;90(6):1623–1631.
   PubMed Web of Science ®Google Scholar
• Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1325–1329.
   PubMed Web of Science ®Google Scholar
• Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev. 2006;15(2): 189–193.
   PubMed Web of Science ®Google Scholar
• Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr. 2007;86(2):271–273.
   PubMed Web of Science ®Google Scholar
• Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133(11 Suppl 1):S3731–S3739.
   PubMed Web of Science ®Google Scholar
• Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51(3):267–292.
   PubMed Web of Science ®Google Scholar
• Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002;62(12):3361–3364.
   Web of Science ®Google Scholar
• Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004; 159(5):423–443.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Giovannucci E, Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2005; 14(3):740–743.
   Web of Science ®Google Scholar
• Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83(4):895–904.
   Web of Science ®Google Scholar
• Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009;101(6):432–35.
   PubMedGoogle Scholar
• Larsson SC, Hakansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst. 2006;98(6):407–413.
   PubMedGoogle Scholar
• Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol. 2001;153(7):680–687.
   Web of Science ®Google Scholar
• Skinner HG, Michaud DS, Giovannucci EL, et al. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol. 2004;160(3):248–258.
   Web of Science ®Google Scholar
• Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, StolzenbergSolomon RZ. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2010;91(2):449–455.
   Web of Science ®Google Scholar
• Shrubsole MJ, Jin F, Dai Q, et al. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res. 2001;61(19):7136–7141.
   PubMed Web of Science ®Google Scholar
• Charles D, Ness AR, Campbell D, Davey SG, Hall MH. Taking folate in pregnancy and risk of maternal breast cancer. BMJ. 2004; 329(7479):1375–1376.
   PubMedGoogle Scholar
• Ganji V Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2003;77(4):826–833.
   Web of Science ®Google Scholar
• Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274(19):1526–1533.
   PubMed Web of Science ®Google Scholar
• Ganji V Kafai MR. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the United States: analysis of data from National Health and Nutrition Examination Surveys, 1988–1994, 1999–2000, and 2001–2002. J Nutr. 2006;136(1):153–158.
   PubMed Web of Science ®Google Scholar
• Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296(22):2720–2726.
   PubMed Web of Science ®Google Scholar
• Lucock M, Yates Z. Folic acid fortification: a double-edged sword. Curr Opin Clin Nutr Metab Care. 2009;12(6):555–564.
   PubMed Web of Science ®Google Scholar
• Ward M, Hutton J, Mc Donnell R, et al. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996–2002. Ir Med J. 2004;97(9):274–276.
   PubMedGoogle Scholar
• de Jong-van den Berg LT, de Walle HE, van der Pal-de Bruin KM, Buitendijk SE, Cornel MC. Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995. Eur J Clin Pharmacol. 1998;54(4):329–331.
   Web of Science ®Google Scholar
• de Walle HE, de Jong-van den Berg LT. Ten years after the Dutch public health campaign on folic acid: the continuing challenge. Eur J Clin Pharmacol. 2008;64(5):539–543.
   Web of Science ®Google Scholar
• Chan A, Pickering J, Haan E, et al. “Folate before pregnancy”: the impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust. 2001; 174(12):631–636.
   Web of Science ®Google Scholar
• Lawrence JM, Watkins ML, Ershoff D, et al. Design and evaluation of interventions promoting periconceptional multivitamin use. Am J Prev Med. 2003;25(1):17–24.
   Web of Science ®Google Scholar
• Amitai Y, Fisher N, Meiraz H, Baram N, Tounis M, Leventhal A. Preconceptional folic acid utilization in Israel: five years after the guidelines. Prev Med. 2008;46(2):166–169.
   Web of Science ®Google Scholar
• Martinez de Villarreal L, Perez JZ, Vazquez PA, et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo Leon, Mexico. Teratology. 2002;66(5):249–256.
   Google Scholar